Overview of ET-1-Induced MCAO Model

Endothelin-1 (ET-1)-induced middle cerebral artery occlusion (MCAO) model induces focal ischemia via stereotactic microinjection of ET-1 to targeted brain regions. It is widely employed for investigating stroke pathophysiology and evaluating therapeutic interventions.

Download

Unlock Insights into Stroke Research | Specialized Experimental Model Solutions

Discover our ET-1-induced MCAO model and accelerate your preclinical stroke research. This tri-brochure will present you with:

Detailed model description: Stereotactic ET-1 injection with real-time cerebral blood flow verification.
Versatile study applications: From pathophysiology studies to preclinical drug efficacy evaluations.
Comprehensive assessments: Behavioral testing, advanced imaging, and molecular/histopathological analyses.
Animal species: Our ET-1-induced MCAO model is available in both rodent and large-animal species to meet diverse research needs and enhance translational value.
End-to-end solutions: Customized protocols, skilled technical execution, and rigorous data analysis.

Whether you are testing candidate drugs or studying secondary injury mechanisms, our ET-1-induced MCAO model delivers the data quality and reliability you need.

Download the brochure now and see how Ace Therapeutics can accelerate your stroke research from concept to clinical impact.

Fill In This Form to Get Our Overview of ET-1-Induced MCAO Model.

Overview of ET-1-Induced MCAO Model

You might be interested in...